People in linQ hail from many walks of life. We seek all who are stakeholders in the healthcare arena. The majority of linQers come from the worlds of medicine, science, and business.

Be a part of linQ
Faculty

Individuals who commit to participate regularly (weekly, or biweekly) for at 5-12 months (depending on the program) as part of a group mentoring team. See our faculty and mentors

Expert Advisors

Individuals who provide teaching, mentorship, or advice in a one-on-one, committee, or class room setting. See our expert advisors

Fellows

Fellows spend full time in one of the linQ immersion programs. Accordingly, they are sometimes referred to as Catalyst Fellows, Converter Fellows or Accelerator Fellows, to indicate their program affiliation. See our Fellows

Clinical Innovators

Clinician who participates on a part-time basis in one of the immersion programs

Business Interns

Business students or recent graduates who join a team in one of the immersion programs.

Trainees

Non-business students who join a team in one of the immersion programs. Their work may be suitable for a thesis for an advanced degree


linQ institutions

linQ faculty represent a wide array of the stakeholders and expertise it takes to bring innovations to impact.

University / Research

  • Boston_University_Wordmark
  • CSIC_logo
  • cien
  • Harvard_Medical_School_seal
  • IO_logo
  • MIT side text red
  • UC3M logoforweb
  • UPM_logo
  • UJRC_logo
  • Wellman_logo

Hospital / Clinical

  • BID_logo
  • BWH_logo
  • ChildrensHospitalBoston1
  • CNIO
  • danafarberlogo
  • Hospital_Clinico_SC_logo
  • Hospital-Fuenlabrada_logo
  • Gregorio Marañon
  • identidad HM definitivo trazado
  • mgh_logo
  • Back
  • NECO logo

Business

  • BioVentures Investors
  • Catabasis
  • cientifica PLC logo
  • Concert logo
  • CRB Inverbio
  • Flex Pharma
  • ie-logo
  • PNP Research logo
  • Union Biometrica-Logo-2015

People

Faculty, Mentors, Expert Advisors, and Fellows of linQ programs to date.

Faculty / mentors
Elfar Adalsteinsson
Massachusetts Institute of Technology

Joseph v. Bonventre
Harvard Medical School

Emery N. Brown
Massachusetts of Institute of Technology

Peter Bryant
IE Business School, Madrid

Deborah Burstein
Beth Israel Deaconess Medical Center

Antje Danielson
MIT Energy Initiative

Joseph DeAngelis
Beth Israel Deaconess Medical Center

Isabela del Alcázar, MBM
Polypeptide Therapeutic Solutions S.L.

Elazer Edelman
Massachusetts Institute of Technology

Conor Evans
Wellman Center for Photomedicine at Massachusetts General Hospital

William Febbo
OptimizeRx Corporation

Peter Feinstein
BioVentures Investors

Javier Fernández
Vitro

Albert Galaburda
Harvard Medical School

Roozbeh Ghaffari
MC10 Inc

Polina Golland
Massachusetts Institute of Technology

Martha Gray
Massachusetts Institute of Technology

Ali Guermazi
Boston University School of Medicine 

Peter Hansen
PNP Research

Tim Harper
Cientifica

Tom Heldt
Massachusetts Institute of Technology

Juan Antonio Hernández Tamames
Universidad Rey Juan Carlos (URJC)

Arthur Hiller
Hiller Life Sciences Strategies

Mary Hochman
Beth Israel Deaconess Medical School

Jacob Hooker
Massachusetts General Hospital

Christiana Iyasere
Massachusetts General Hospital

Kevin King
Brigham and Women’s Hospital

Petra Krauledat
PNP Research

María Jesús Ledesma-Carbayo
Universidad Politécnica de Madrid (UPM)

Umar Mahmood
Massachusetts General Hospital

Maulik D. Majmudar
Massachusetts General Hospital

Norberto Malpica González
Universidad Rey Juan Carlos

Julio Mayol
Hospital Clínico San Carlos

Richard (Rick) Mitchell
Brigham and Women’s Hospital

Rick Modi
Catabasis Pharmaceuticals

Francisca Mulero
Spanish National Cancer Research Center (CNIO)

Arrate Muñoz-Barrutia
Universidad Carlos III – Gregorio Marañon Health Research Institution

Asif Naseem
PDS

Lauren O’Donnell
Harvard Medical School

Timothy P. Padera
Massachusetts General Hospital

Etta Pisano
Beth Israel Deaconess Medical Center

Mark Poznansky
Massachusetts General Hospital

Juan José Rios Blanco
Hospital Universitario “La Paz”

Raúl San José Estépar
Brigham and Women’s Hospital

Ángel Santos
CRB Inverbío

Erik Sobel
Technology Research Laboratories

Simona Socrate
Massachusetts Institute of Technology

Bryan Strange
Center for Biomedical Technology (CTB) – UPM

Collin Stultz
Massachusetts Institute of Technology

Barbara Taylor
OvaScience

Zach Taylor
Neon Therapeutics

Ronald G. Tompkins
Harvard Medical School

Mehmet Toner
Massachusetts General Hospital

Robert Tung
Concert Pharmaceuticals

Benjamin Vakoc
Massachusetts General Hospital

Tom Vettenburg
Universidad Carlos III de Madrid (UC3M)

Lawrence Wald
Massachusetts General Hospital

Thomas Wessel
Flex-Pharma



Expert advisors
José Ignacio Andrés
Janssen Research & Development

Alfonso Antequera, FACS
Hospital Universitario de Fuenlabrada

Jorge Bensadón Belicha
VITRO

David Boas
Massachusetts General Hospital

Brett Bouma
Massachusetts General Hospital

Jorge Conde
Knome Inc.

Gabriel Cristobal
Spanish Council for Scientific Research

Jean-Jacques Degroof
MIT Industrial Performance Center

Francisco del Pozo
Center for Biomedical Technology (CTB) – UPM

Manuel Desco Méndez
Universidad Carlos III Madrid

Eduardo Díaz Sánchez
Fundación para el Conocimiento madri+d

Robert (Bob) Edelman
NorthShore University Health System

Georges El Fakhri, DABR
Massachusetts General Hospital

Jeffrey Evelhoch
Merck & Co., Inc.

Carlos Gabás
AstraZeneca

Randy Gollub
Massachusetts General Hospital

Ellen Grant
Children’s Hospital Boston, Harvard Medical School

Mark Griswold
Case Western Reserve University

Rajiv Gupta
Massachusetts General Hospital

Gonzalo Herradón
Universidad CEU-San Pablo

Daphne Holt
Massachusetts General Hospital

Pablo Irarrázaval
Pontificia Universidad Catolica de Chile

Stanley Lapidus
SynapDx Corporation

Michael Lev
Massachusetts General Hospital

Antonio López
Science & Innovation Link Office (SILO)

María Luaces Méndez
Hospital Clínico San Carlos, Madrid

Bruno Madore
Brigham and Women’s Hospital

Umar Mahmood
Massachusetts General Hospital, Radiology

Susana Marcos
Spanish Council for Scientific Research

Isaac Martin Barbero
ICEX

Susana Martín
Universidad Politécnica de Madrid (UPM)

Tatiana Masarrah
Hospital General Universitario Gregorio Marañón

Wojciech Matusik
Massachusetts Institute of Technology

Tom C. Meyers
Brown Rudnick LLP

Rudy Mitchell, EdD
Massachusetts Institute of Technology

Ralph Müller
Eidgenössische Technische Hochschule Zurich (ETH)

Fiona Murray
Massachusetts Institute of Technology

Asif Naseem
Mason Wells Private Equity

Robert Padera
Brigham and Women’s Hospital

Javier Pascau
Universidad Carlos III Madrid

Iván Pedrosa
University of Texas Southwestern

Charles Peterfy
Spire Sciences, LLC

Jorge Ripoll
Universidad Carlos III Madrid

Jesús Ruiz-Cabello
Universidad Complutense Madrid (Centro Citometra y Microscopa de Fluorescencia)

Frank Rybicki
Brigham and Women’s Hospital

Priscilla Slanetz, MPH
Beth Israel Deaconess Medical Center

Daniel Sodickson
New York University School of Medicine

Gregory Sorensen
Siemens

Scott Stern
Massachusetts Institute of Technology

Kaushik Sunder Rajan
University of Chicago

Frank Thorn, O.D.
The New England College (NECO)

Frances Toneguzzo
Massachusetts General Hospital

Antonio Torralba
Massachusetts Institute of Technology

Bruce Tromberg
University of California, Irvine

José Manuel Udías
Universidad Complutense Madrid (Centro Citometra y Microscopa de Fluorescencia)

Trudy van Houten
Brigham and Women’s Hospital

Juan José Vaquero
Universidad Carlos III Madrid

Torunn Yock
Massachusetts General Hospital

Lilla Zollei
Massachusetts General Hospital



Catalyst Fellows

Please write to enorman@mit.edu to suggest a correction.